SIGA Technologies Inc. (SIGA): Price and Financial Metrics


SIGA Technologies Inc. (SIGA): $8.99

0.18 (+2.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SIGA to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

SIGA POWR Grades

  • Growth is the dimension where SIGA ranks best; there it ranks ahead of 99.11% of US stocks.
  • SIGA's strongest trending metric is Quality; it's been moving down over the last 178 days.
  • SIGA ranks lowest in Stability; there it ranks in the 0th percentile.

SIGA Stock Summary

  • The ratio of debt to operating expenses for SIGA TECHNOLOGIES INC is higher than it is for about only 0.52% of US stocks.
  • Over the past twelve months, SIGA has reported earnings growth of 541.51%, putting it ahead of 96.71% of US stocks in our set.
  • As for revenue growth, note that SIGA's revenue has grown 283.24% over the past 12 months; that beats the revenue growth of 96.73% of US companies in our set.
  • Stocks that are quantitatively similar to SIGA, based on their financial statements, market capitalization, and price volatility, are HSTO, NURO, RNWK, KMDA, and FEIM.
  • SIGA's SEC filings can be seen here. And to visit SIGA TECHNOLOGIES INC's official web site, go to www.siga.com.

SIGA Valuation Summary

  • SIGA's EV/EBIT ratio is 3.8; this is 55.81% lower than that of the median Healthcare stock.
  • Over the past 236 months, SIGA's price/sales ratio has gone down 40.3.

Below are key valuation metrics over time for SIGA.

Stock Date P/S P/B P/E EV/EBIT
SIGA 2022-11-25 3.0 3.7 6.0 3.8
SIGA 2022-11-23 3.1 3.9 6.2 4.0
SIGA 2022-11-22 3.2 3.9 6.3 4.1
SIGA 2022-11-21 3.1 3.9 6.2 4.0
SIGA 2022-11-18 3.1 3.8 6.2 4.0
SIGA 2022-11-17 3.1 3.9 6.2 4.1

SIGA Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at -5.73%.
  • Its year over year revenue growth rate is now at 9.63%.
  • The 3 year net income to common stockholders growth rate now stands at -83.93%.
Over the past 33 months, SIGA's revenue has gone up $188,032,634.

The table below shows SIGA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 214.7747 65.81985 107.9236
2022-06-30 147.4098 72.22988 71.76968
2022-03-31 139.396 73.00736 69.90182
2021-12-31 133.6705 11.49464 69.45077
2021-09-30 56.04256 41.33845 16.40516
2021-06-30 95.4578 71.04887 43.70648

SIGA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SIGA has a Quality Grade of A, ranking ahead of 98.42% of graded US stocks.
  • SIGA's asset turnover comes in at 0.402 -- ranking 116th of 682 Pharmaceutical Products stocks.
  • INFI, TTNP, and PALI are the stocks whose asset turnover ratios are most correlated with SIGA.

The table below shows SIGA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.402 0.899 0.927
2021-06-30 0.677 0.883 1.972
2021-03-31 0.924 0.883 2.388
2020-12-31 0.943 0.882 2.253
2020-09-30 0.632 0.884 1.360
2020-06-30 0.346 0.896 0.269

SIGA Stock Price Chart Interactive Chart >

Price chart for SIGA

SIGA Price/Volume Stats

Current price $8.99 52-week high $26.99
Prev. close $8.81 52-week low $5.84
Day low $8.70 Volume 985,500
Day high $9.06 Avg. volume 5,572,263
50-day MA $9.48 Dividend yield N/A
200-day MA $10.91 Market Cap 656.49M

SIGA Technologies Inc. (SIGA) Company Bio


SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.


SIGA Latest News Stream


Event/Time News Detail
Loading, please wait...

SIGA Latest Social Stream


Loading social stream, please wait...

View Full SIGA Social Stream

Latest SIGA News From Around the Web

Below are the latest news stories about SIGA TECHNOLOGIES INC that investors may wish to consider to help them evaluate SIGA as an investment opportunity.

Here's Why SIGA Technologies (NASDAQ:SIGA) Has Caught The Eye Of Investors

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Yahoo | November 5, 2022

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022

- Approximately $61 Million of International Sales in the Third Quarter – - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2022. “With significant international sales, our third quarter financial results continue a trend of substantial financial diversification at SIGA,” said

Yahoo | November 3, 2022

Monkeypox remains a global health emergency – WHO

An expert panel of the World Health Organization (WHO) has agreed to keep the emergency designation for the ongoing monkeypox outbreak, the global body announced on Tuesday.

In July, WHO called the multi-country outbreak a public health emergency of international concern (PHEIC), aiming to generate a coordinated global response against the virus.

PHEIC designation, the agency’s highest level of warning, previously issued for the COVID-19 pandemic and Ebola, is intended to unlock funding to share vaccines and therapeutics.

At a meeting in October, WHO’s Emergency Committee, however, noted the recent progress made to contain the virus, which has led to over 77K confirmed cases, including 23 deaths globally this year, according to data from the Seeking Alpha | November 1, 2022

SIGA Technologies to Host Business Update Call on November 3rd, 2022 Following Release of Third Quarter 2022 Financial Results

NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, November 3rd, 2022. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at www.siga.com und

Yahoo | October 27, 2022

Dear Revlon (REV) Stock Fans, Prepare for Delisting

REV stock will be delisted soon.

Larry Ramer on InvestorPlace | October 21, 2022

Read More 'SIGA' Stories Here

SIGA Price Returns

1-mo -2.71%
3-mo -40.38%
6-mo -30.15%
1-year 10.44%
3-year 83.47%
5-year 87.68%
YTD 19.55%
2021 3.44%
2020 52.41%
2019 -39.62%
2018 62.89%
2017 68.40%

Continue Researching SIGA

Here are a few links from around the web to help you further your research on Siga Technologies Inc's stock as an investment opportunity:

Siga Technologies Inc (SIGA) Stock Price | Nasdaq
Siga Technologies Inc (SIGA) Stock Quote, History and News - Yahoo Finance
Siga Technologies Inc (SIGA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9354 seconds.